Bill > HF747

This bill modifies the requirements for prior authorization of prescription drugs and mandates greater transparency in prescription drug benefits provided by health plan companies. Key provisions include: 1. Requiring prior authorizations for prescription drugs to remain valid for the duration of an enrollee's contract term, or one year for those enrolled in MinnesotaCare or Medical Assistance, as long as certain conditions are met (e.g., the drug continues to be prescribed, is not deemed unsafe, and there is no evidence of enrollee abuse). 2. Requiring health plan companies to make their prescription drug formularies and related benefit information publicly available at least 30 days prior to annual renewal dates, organized consistent with the United States Pharmacopeia's guidelines. 3. Allowing health plan companies to make certain formulary changes during the enrollee's contract year, such as adding drugs or reducing cost-sharing, but restricting their ability to remove brand-name drugs or increase cost-sharing without providing 60-day notice. 4. Applying the new prescription drug benefit transparency and management requirements to managed care plans and county-based purchasing plans under MinnesotaCare and Medical Assistance programs.

Budget and Finance, Business and Industry

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF0747&ssn=0&y=2017